Countstar


Hong Kong media: China has made positive progress in stem cell research

Abstract: China's efforts to narrow the gap between stem cell research and the west have not been in vain. Unlike other countries, where research is subject to tight regulation and intense debate, China has made significant investments in stem cell research over the past five years.

Hong Kong's south China morning post reported on May 17 that the original title: China has been making efforts to narrow the gap between stem cell research and the west have paid off. Unlike other countries, where research is subject to tight regulation and intense debate, China has made significant investments in stem cell research over the past five years.

Ten years ago, China published only 37 relevant papers in prestigious academic journals; by 2008, there were 1,116. China ranks fifth in both the number of stem cell patents and the number of papers published.

While embryonic stem cell research in the west is controversial, Beijing is racing ahead. The Chinese government has spent billions of yuan on stem cell research in hopes of finding innovative treatments for deadly diseases such as heart disease, liver failure and Parkinson's disease.

Ronald Lee, director of the stem cell and reproductive medicine association at the university of Hong Kong, said China's active involvement in biomedicine would not only enhance its technological prowess but also help build a knowledge-based economy. As in other areas of research, the quality of stem cell research in China varies widely, but some of it is extremely high. Overall, China is making positive progress in stem cell research.
Related News